Evidence map›Paper›PMID 33102427›Full record

ArticleFrontiers in chemistry2020

Comprehensive Protocol for the Identification and Characterization of New Psychoactive Substances in the Service of Law Enforcement Agencies.

Ewa Bulska, Robert Bachliński, Michał K Cyrański, Magdalena Michalska-Kacymirow, Wioletta Kośnik, Paweł Małecki, Karol Grela, Michał A Dobrowolski

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ewa BulskaFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Robert BachlińskiCentral Forensic Laboratory of the Police, Warsaw, Poland.
Michał K CyrańskiFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Magdalena Michalska-KacymirowFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Wioletta KośnikFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Paweł MałeckiFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Karol GrelaFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.
Michał A DobrowolskiFaculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A non-routine, comprehensive protocol for characterization of emerging new psychoactive substances (NPS) including chemical structures, impurities, as well as crystal structures, has been developed to facilitate the work of law enforcement agencies. A set of NPS has been synthesized, identified, and characterized by various analytical methods in order to be used as certified reference standards (CRMs). Seven selected compounds (5-IT, NM-2201, MT-45, AB-CHMINACA, UR-144, 5F-PB-22, and 4-CMC) were synthesized on the laboratory scale, then the process was upscaled to semi-technical. All products were analyzed by electrospray Q/TOF-MS/MS for molecular structure identification. The presence of by-products, as well as metal impurities, arising from the performed syntheses, were characterized by reversed phase liquid chromatography (RP-HPLC) with DAD and Q/TOF-MS detection and inductively-coupled plasma with quadrupole mass spectrometer (ICP-QMS), respectively. Additionally, the crystal structures of UR-144, NM-2201, 5F-PB-22, and 4-CMC have been determined by single-crystal and powder X-ray diffraction.

Indexed as

ES Q/TOF MS/MSLC-Q/TOFnew psychoactive substance (NPS)synthetic cannabinoid (SC)X-ray diffraction

Identifiers

PMID33102427
PMCPMC7546804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.